Submitted by Anonymous (not verified) on 17 December 2025 - 12:58
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Date of authorisation: 04/04/2025, Revision: 3, Status: Authorised